Increased risk of severe cutaneous adverse reactions when cladribine is used together with other medications with a propensity for skin reactions-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Increased risk of severe cutaneous adverse reactions when cladribine is used together with other medications with a propensity for skin reactions

Published:2022-07-28 Issue:12 Volume:63 Page:2965-2974
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Haynes Janice¹,Jackson Maria²,Smugar Steven S.³

Affiliation:

1. Global Medical Safety department, Janssen R&D, Horsham, PA, USA

2. Global Medical Safety department, Janssen R&D UK, High Wycombe, UK

3. Global Medical Safety department, Janssen R&D, Titusville, NJ, USA

Funder

Janssen R&D, LLC

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2022.2100370

Reference30 articles.

1. Hairy cell leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2. Hairy Cell Leukemia, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology

3. Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

4. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL

5. Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the Group C protocol mechanism of the National Cancer Institute: a report of 979 patients.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cladribine;Reactions Weekly;2023-07-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP